Amorphous HMG-CoA reductase inhibitors of desired particle size
US7230120B2 · kind B2 · utility
7Cited by
4References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 18, 2002 |
| Grant date | Jun 12, 2007 |
| Priority date | — |
| Expiry date | Oct 6, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2602/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
In one aspect, the invention provides a process for the preparation of an amorphous HMG-CoA reductase inhibitor and hydrates thereof of desired particle size, which comprises: dissolving the HMG-CoA reductase inhibitor in a hydroxylic solvent, and removing the solvent by freeze-drying.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.